Since E-Cadherin suppression in cancer cells enhances the development of migratory and invasive phenotype and facilitates dissociation from the surrounding extracellular matrix of the primary tumor site [5], we suggest that GPC3 would induce MET by regulating E-Cadherin expression. The gene discussed is CDH1; the disease is cancer.